Outsourced Pharma Capacity Update Videos - Large Molecule

  1. Boehringer Ingelheim Biopharmaceuticals GmbH Capacity Update October 2025: Large Molecule 10/16/2025

    This session provides a comprehensive overview of our biopharmaceutical contract manufacturing services for mammalian cell culture and microbial technologies.

  2. Abzena Capacity Update October 2025: Large Molecule 10/16/2025

    Accelerate your therapeutic antibody and complex protein development with advanced mammalian cell line platforms that move from DNA to RCB in just 10 weeks.

  3. Resilience Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Hear from Evan Pasenello, Head of Commercial Services, about how Resilience can support large molecule programs from early phase through clinical and commercial manufacturing.

  4. Novartis Contract Manufacturing Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Review biologics CDMO solutions and capacity offered by Novartis Contract Manufacturing. We discuss our capabilities in mammalian cell culture manufacturing and microbial fermentation.

  5. Providing Development And Supply Of Life-Changing Medicines 7/28/2025

    Review the strategic application of extensive expertise in microbial systems to meet the increasing demand for novel biologics. Cutting-edge capabilities ensure streamlined development and manufacturing processes.

  6. Cytovance Biologics Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Thomas Kohl, Director of Business Development, shares the company’s microbial and mammalian capabilities and their available capacity. Cytovance delivers ingenuity end-to-end to both large pharma and biotech clients alike.

  7. Aragen Capacity Update July 2025: Large Molecule Drug Substance 7/28/2025

    Aragen’s newly built cutting-edge biologics manufacturing facility launches with GMP capabilities from 50L to 2000L—scaling to 5000L soon—with a DP filling line and ADC conjugation suite set to redefine bioproduction in India.

  8. Northway Biotech Capacity Update April 2025: Large Molecule Development 4/22/2025

    Detra Glinatsis, Vice President of Business Development, presents the advanced capabilities, strategic growth, and expanding capacity of Northway Biotech, a global biologics CDMO.

  9. Abzena Capacity Update April 2025: Large Molecule Development 4/22/2025

    See first-hand how AbZelectPRO™, an evolved approach to cell line development, can simplify selection, enhance stability, and de-risk your program for faster regulatory approval.

  10. Curia Capacity Update April 2025: Large Molecule Development 4/22/2025

    Site head Bill Hermans showcases our facility's specialized capabilities in Hopkinton, Massachusetts, and shares how our team serves as a true scientific partner to clients.